See also this year's filing and all EDGAR filings for this company.
PDF Report 0000827871_2017_Eagle_Pharmaceuticals_INC.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
Graph
Absolute values for 0000827871, Eagle Pharmaceuticals INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 109,110,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 73,115,000 |
| 2 | PropertyPlantAndEquipmentNet | 3,316,000 |
| 3 | remainder_Assets | 28,779,000 |
| 4 | LiabilitiesCurrent | 40,965,000 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 52,313,000 |
| 9 | ResearchAndDevelopmentExpense | 30,262,000 |
| 10 | remainder_Expenses | 25,530,000 |
| 11 | remainder_Revenues | 189,482,000 |
| 12 | remainder_NetIncome | 76,000 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 214,320,000 |
| 1 | Liabilities | 40,965,000 |
| 2 | Expenses | 108,105,000 |
| 3 | Revenues | 189,482,000 |
| 4 | StockholdersEquity | 173,355,000 |
| 5 | NetIncome | 81,453,000 |
| 6 | ComprehensiveNetIncome | 81,453,000 |
| 7 | BaseVar | 276,474,000 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 3.60 |
| 9 | EconomicCapitalRatio | 4.10 |
Edgar->Model Mapping
Feature Distribution
Change over Time
